CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on RNA editing for rare and ...

Three Vietnamese researchers in Hong Kong have solved a 20-year puzzle in molecular biology that could reshape how scientists develop cancer treatments based on RNA interference.

Reviewing the role, regulatory mechanisms and therapeutic potential of METTL16 in cancer Cancer remains a leading cause of mortality, with its onset ...

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

A recent study by Fred Hutch biochemist Christopher Lapointe, PhD, and his colleagues, uses innovative lab techniques to ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

GLP toxicology studies ongoing for CMP-002, with initiation of global Phase 1/2 clinical trial in SYNGAP1 patients expected as early as 2H ...

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected ...

Researchers from Duke Health and the University of Minnesota recently discovered that measuring specific tiny genetic ...

Inside every cell, thousands of molecular signals collide, overlap, and compensate, obscuring the true drivers of gene expression.

Exosomes are emerging as the go-to serum for looking refreshed but natural. Experts share how the regenerative ingredient ...